The role of surrogate endpoints in the evaluation of efficacy and safety of therapeutic interventions in diabetes mellitus.
about
Double-blind, randomized, multicentre, and active comparator controlled investigation of the effect of pioglitazone, metformin, and the combination of both on cardiovascular risk in patients with type 2 diabetes receiving stable basal insulin therapSurrogate outcomes: experiences at the Common Drug Review.Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39).Ethical challenges with welfare technology: a review of the literature.Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing.
P2860
The role of surrogate endpoints in the evaluation of efficacy and safety of therapeutic interventions in diabetes mellitus.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@en
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@nl
type
label
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@en
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@nl
prefLabel
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@en
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@nl
P2093
P2860
P356
P1476
The role of surrogate endpoint ...... ventions in diabetes mellitus.
@en
P2093
Aleksandra Wieczorek
Iwona Skrzekowska-Baran
Maciej Malecki
Przemyslaw Rys
P2860
P304
P356
10.1900/RDS.2008.5.128
P577
2008-11-10T00:00:00Z